We innovate diagnostic efficiency

IVD products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers.

Explore now

New call-to-action

AHEAD of market needs

ADDRESSING HIGH-VALUE MARKETS

Fast-growing developer and manufacturer of innovative and efficient diagnostics for better treatment decisions. Learn more about the roadmap for our portfolio of high-impact diagnostic tests.

 


WATCH COMPANY PRESENTATION HERE

Efficient diagnostics

Moving assays to clinical chemistry

Learn more about how we innovate diagnostic efficiency by developing and producing accurate diagnostic tests that save time and costs for both laboratories and patients.


READ MORE

biomarkers in growing demand

RELEVANT PRODUCT SOLUTIONS

Gentian's portfolio and pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine.


FIND OUT MORE

serving laboratories and industry partners

global market reach

We serve the global market for human and veterinary medical diagnostics tests via our OEM partners, key distributors, and healthcare providers. We are always eager to explore business opportunities with new and current partners. 


EXPLORE PRODUCTS

LATEST NEWS

Cystatin C testing - Balancing additional costs against potential benefits

11. Apr 2024

Cystatin C testing - Balancing additional costs against potential benefits

The KDIGO (Kidney Disease: Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and..

Scientists to Gentian’s R&D department

08. Apr 2024

Scientists to Gentian’s R&D department

Scientists to Gentian’s application validation group We are looking for two new colleagues in the positions..

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

03. Apr 2024

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

The global non-profit organisation KDIGO (Kidney Disease: Improving Global Outcomes), commits to create and..